Author:
Clark Joshua J.,Secrest Aaron M.,Hull Christopher M.,Eliason Mark J.,Leiferman Kristin M.,Gleich Gerald J.,Powell Douglas L.
Reference5 articles.
1. The impact of chronic urticaria on the quality of life;O'Donnell;Br J Dermatol,1997
2. Genentech I. Xolair (omalizumab) for subcutaneous use: Full prescribing information. Line 47-52, Page 1. Date of Revision, 3/21/2014. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103976s5211lbl.pdf. Accessed August 30, 2015.
3. Treatment of chronic autoimmune urticaria with omalizumab;Kaplan;J Allergy Clin Immunol,2008
4. An algorithm for treating chronic urticaria with omalizumab: Dose interval should be individualized;Uysal;J Allergy Clin Immunol,2014
5. Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review;Carrillo;World Allergy Organ J,2014
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献